Direct TLR2 Signaling Is Critical for NK Cell Activation and Function in Response to Vaccinia Viral Infection

被引:98
作者
Martinez, Jennifer [1 ]
Huang, Xiaopei [2 ]
Yang, Yiping [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
NATURAL-KILLER-CELLS; DOUBLE-STRANDED-RNA; DENDRITIC CELLS; IFN-GAMMA; VIRUS; RECOGNITION; RECEPTORS; CYTOMEGALOVIRUS; BIOTERRORISM; CYTOTOXICITY;
D O I
10.1371/journal.ppat.1000811
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Natural killer (NK) cells play an essential role in innate immune control of poxviral infections in vivo. However, the mechanism(s) underlying NK cell activation and function in response to poxviruses remains poorly understood. In a mouse model of infection with vaccinia virus (VV), the most studied member of the poxvirus family, we identified that the Toll-like receptor (TLR) 2-myeloid differentiating factor 88 (MyD88) pathway was critical for the activation of NK cells and the control of VV infection in vivo. We further showed that TLR2 signaling on NK cells, but not on accessory cells such as dendritic cells (DCs), was necessary for NK cell activation and that this intrinsic TLR2-MyD88 signaling pathway was required for NK cell activation and played a critical role in the control of VV infection in vivo. In addition, we showed that the activating receptor NKG2D was also important for efficient NK activation and function, as well as recognition of VV-infected targets. We further demonstrated that VV could directly activate NK cells via TLR2 in the presence of cytokines in vitro and TLR2-MyD88-dependent activation of NK cells by VV was mediated through the phosphatidylinositol 3-kinase (PI3K)-extracellular signal-regulated kinase (ERK) pathway. Taken together, these results represent the first evidence that intrinsic TLR signaling is critical for NK cell activation and function in the control of a viral infection in vivo, indicate that multiple pathways are required for efficient NK cell activation and function in response to VV infection, and may provide important insights into the design of effective strategies to combat poxviral infections.
引用
收藏
页数:13
相关论文
共 42 条
[1]   Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity [J].
Andoniou, CE ;
van Dommelen, SLH ;
Voigt, V ;
Andrews, DM ;
Brizard, G ;
Asselin-Paturel, C ;
Delale, T ;
Stacey, KJ ;
Trinchieri, G ;
Degli-Esposti, MA .
NATURE IMMUNOLOGY, 2005, 6 (10) :1011-1019
[2]   Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors [J].
Arase, H ;
Mocarski, ES ;
Campbell, AE ;
Hill, AB ;
Lanier, LL .
SCIENCE, 2002, 296 (5571) :1323-1326
[3]   The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46 [J].
Arnon, TI ;
Achdout, H ;
Lieberman, N ;
Gazit, R ;
Gonen-Gross, T ;
Katz, G ;
Bar-Ilan, A ;
Bloushtain, N ;
Lev, M ;
Joseph, A ;
Kedar, E ;
Porgador, A ;
Mandelboim, O .
BLOOD, 2004, 103 (02) :664-672
[4]   SAFETY OF RECOMBINANT VACCINIA VACCINES [J].
BAXBY, D .
LANCET, 1991, 337 (8746) :913-913
[5]   Hemagglutinin protein of wild-type measles virus activates Toll-like receptor 2 signaling [J].
Bieback, K ;
Lien, E ;
Klagge, IM ;
Avota, E ;
Schneider-Schaulies, J ;
Duprex, WP ;
Wagner, H ;
Kirschning, CJ ;
ter Meulen, V ;
Schneider-Schaulies, S .
JOURNAL OF VIROLOGY, 2002, 76 (17) :8729-8736
[6]   SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS [J].
BIRON, CA ;
BYRON, KS ;
SULLIVAN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) :1731-1735
[7]   Smallpox and smallpox vaccination - Neurological implications [J].
Booss, J ;
Davis, LE .
NEUROLOGY, 2003, 60 (08) :1241-1245
[8]   Progressive vaccinia [J].
Bray, M ;
Wright, ME .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (06) :766-774
[9]   Vital involvement of a natural killer cell activation receptor in resistance to viral infection [J].
Brown, MG ;
Dokun, AO ;
Heusel, JW ;
Smith, HRC ;
Beckman, DL ;
Blattenberger, EA ;
Dubbelde, CE ;
Stone, LR ;
Scalzo, AA ;
Yokoyama, WM .
SCIENCE, 2001, 292 (5518) :934-937
[10]  
BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531